Skip to main content
Business

A failed trial for a heart drug casts shadow over rivals developing similar therapies

A failed trial for a heart drug casts shadow over rivals developing similar therapies

Feed excerpt — reported by MarketWatch

The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at MarketWatch →

Original Source

This article was syndicated from MarketWatch. All rights remain with the original publisher.